The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...

If you don’t have any allergies, you might not realize just how many people (hey!) are envious of you. A whopping 30% to 40% ...

The Race to Stay First, the Scramble to Escape Last Consider what happens every quarter inside companies that use stack ...